Mineralocorticoid receptor antagonist (MRA) Kerendia (finerenone) – one of Bayer's top growth prospects – is already approved ...

Generating good-quality patient experience data (PED) is becoming increasingly important for medicine development, and ...

Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi ...

Six months after Paul Chaplin said he was stepping down as chief executive of Bavarian Nordic, the Danish biopharma has named ...

Novo has added Anthropic's Claude to its drug discovery toolkit, shortly after the tech firm revealed a new AI workbench for ...

Chinese tech giant ByteDance – best known as the parent of social media app TikTok – has completed a $290 million financing ...

AI company Anthropic has launched a new large language model (LLM) – Claude Fable 5 – claiming its capabilities as a tool for drug discovery and scientific research gives it a big lead over other ...

Curium's radioligand therapy Bexlutry has been approved in the US as a generic – or 'radioligand equivalent' (RLE) – of ...

The expedited IND programme will allow trial sponsors to partner with a set of qualified research institutions (QRIs) to review IND applications in rolling parts, rather than all at once, and aims to ...

UK-headquartered Beacon Therapeutics has raised a whopping $170 million in second-round financing that will be used to advance a gene therapy for an inherited cause of blindness through a pivotal ...

Wales has recommended ALK's EURneffy nasal spray as the first needle-free option for the emergency treatment of severe ...

The Danish Group stated that the new corporate culture – dubbed 'The Novo Way' – centres around four Cs; namely, customer ...